Synopsis of recent research by authors named "Isabelle Fajac"
- Isabelle Fajac's recent research focuses on advancements in the treatment and care of cystic fibrosis (CF), exploring new drugs, treatment guidelines, and the impact of CFTR modulator therapies on patient health and quality of life.
- Key findings highlight the necessity of multidisciplinary care approaches for managing CF, the importance of expanding eligibility for CFTR modulators like elexacaftor/tezacaftor/ivacaftor, and the ongoing clinical challenges despite improved treatment outcomes.
- Fajac also emphasizes the need for innovative clinical trial designs to accommodate the unique requirements of the CF population, particularly those with rare mutations unresponsive to current therapies, while acknowledging the shift in the disease landscape due to advancements in modulator therapies.
